Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Other Operating Expenses (2016 - 2025)

Jaguar Health (JAGX) has disclosed Other Operating Expenses for 11 consecutive years, with $2.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Operating Expenses fell 0.86% to $2.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $11.8 million, a 31.67% increase, with the full-year FY2024 number at $9.6 million, up 8.78% from a year prior.
  • Other Operating Expenses was $2.5 million for Q3 2025 at Jaguar Health, down from $3.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $4.2 million in Q1 2021 to a low of $1.9 million in Q1 2024.
  • A 5-year average of $2.7 million and a median of $2.6 million in 2022 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: tumbled 53.11% in 2021, then skyrocketed 60.6% in 2025.
  • Jaguar Health's Other Operating Expenses stood at $2.8 million in 2021, then dropped by 19.2% to $2.2 million in 2022, then rose by 15.43% to $2.6 million in 2023, then rose by 26.38% to $3.3 million in 2024, then fell by 22.71% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Other Operating Expenses are $2.5 million (Q3 2025), $3.0 million (Q2 2025), and $3.0 million (Q1 2025).